Envestnet Portfolio Solutions’s Biogen BIIB Stock Holding History

Envestnet Portfolio Solutions’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$376K	Buy	1,738 +296	+21%	+$56.6K	﹤0.01%	1092
2026 Q1	$264K	Sell	1,442 -210	-13%	-$38.7K	﹤0.01%	1167
2025 Q4	$291K	Buy	+1,652	New	+$270K	﹤0.01%	1294
2025 Q1	–	Sell	-2,374	Closed	-$363K	–	1565
2024 Q4	$363K	Sell	2,374 -901	-28%	-$152K	﹤0.01%	1402
2024 Q3	$635K	Sell	3,275 -238	-7%	-$49.8K	﹤0.01%	1075
2024 Q2	$814K	Buy	3,513 +218	+7%	+$47.4K	﹤0.01%	935
2024 Q1	$711K	Buy	3,295 +76	+2%	+$17.8K	﹤0.01%	971
2023 Q4	$833K	Sell	3,219 -20,761	-87%	-$5.1M	﹤0.01%	846
2023 Q3	$6.16M	Buy	+23,980	New	+$6.41M	0.03%	262

Other funds holding BIIB

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ADEF

Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return

Envestnet Portfolio Solutions's BIIB Position: Q2 2026 in Review

Envestnet Portfolio Solutions increased its Biogen (BIIB) stake by 21% in Q2 2026, buying an estimated $56.6K and bringing the position to 1,738 shares worth $376K. The position accounts for ﹤0.01% of the portfolio, ranked #1092.

Envestnet Portfolio Solutions first reported a position in BIIB in Q3 2023 and has held it in 9 quarters since. The position peaked at $6.16M in Q3 2023. 405 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Envestnet Portfolio Solutions held 1,738 shares of Biogen worth $376K as of Q2 2026.
Envestnet Portfolio Solutions bought 296 Biogen shares in Q2 2026, an estimated $56.6K.
Biogen made up ﹤0.01% of Envestnet Portfolio Solutions's portfolio in Q2 2026, its #1092 holding.
Envestnet Portfolio Solutions first reported a position in Biogen in Q3 2023 and has held it in 9 quarters since.
Envestnet Portfolio Solutions's Biogen position peaked at $6.16M in Q3 2023.
405 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.